Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: Evidence for it being a hepatitic form of PBC in genetically susceptible individuals

Hepatology

Volumn 29, Issue 4, 1999, Pages 1078-1084

  Lohse, Ansgar W ^a   Zum Büschenfelde, Karl Hermann Meyer ^a   Franz, Beate ^a   Kanzler, Stephan ^a   Gerken, Guido ^a   Dienes, Hans Peter ^b  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; HLA B8 ANTIGEN; HLA DR3 ANTIGEN; HLA DR4 ANTIGEN; MITOCHONDRION ANTIBODY; STEROID;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE HEPATITIS; BILE DUCT DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL;

EID: 20644452022     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290409     Document Type: Article

References (33)

1. Johnson PJ, McFarlane IG, Eddleston ALWF. The natural course and heterogeneity of autoimmune-type chronic active hepatitis. Semin Liver Dis 1991;11:187-196.
2. Krawitt EL. Autoimmune hepatitis. N Engl J Med 1996;334:897-903.
3. Manns M. Autoantibodies and antigens in liver diseases-updated. J Hepatol 1989;9:272-280.
4. Treichel U, Gerken G, Rossol S, Rotthauwe HW, Meyer zum Büschenfelde KH, Poralla T. Autoantibodies against the human asialoglycoprotein receptor: effects of therapy in autoimmune and virus-induced chronic active hepatitis. J Hepatol 1993;19:55-63.
5. Mackay IR, Tait DB. HLA associations with autoimmune type chronic active hepatitis: identification of B8-DRw3 haplotype by family studies. Gastroenterology 1980;79:95-101.
6. Seki T, Kiyosawa K, Inoko H, Ota M. Association of autoimmune hepatitis with HLA-Bw54 and DR4. HEPATOLOGY 1990;12:1300-1304.
7. Donaldson P, Doherty D, Underbill J, Williams R. The molecular genetics of autoimmune liver disease. HEPATOLOGY 1994;20:225-239.
8. Dienes HP, Popper H, Manns M, Baumann W, Thoenes W, Meyer zum Büschenfelde KH. Histologic features in autoimmune hepatitis. Z Gastroenterol 1989;27:325-330.
9. Bach N, Thung SN, Schaffner F. The histological features of chronic hepatitis C and autoimmune chronic hepatitis: a comparative study. HEPATOLOGY 1992;15:572-577.
10. Portmann B, Popper H, Neuberger J, Williams R. Sequential and diagnostic features in primary biliary cirrhosis based on serial histologic study in 209 patients. Gastroenterology 1985;88:1777-1790.
11. Mackay IR, Gershwin ME. Primary biliary cirrhosis: current knowledge, perspective and future directions. Semin Liver Dis 1989;9:149-157.
12. Gershwin ME, Coppel RL, Mackay IR. Primary biliary cirrhosis and mitochondrial autoantigens. Insights from molecular biology. HEPATOLOGY 1988;8:147-151.
13. Van de Water J, Cooper A, Surh CD, Coppel R, Danner D, Ansari A, Dickson R. Detection of autoantibodies to the recombinant 74 kD and 52 kD mtiochondrial autoantigens of primary biliary cirrhosis. N Engl J Med 1989;320:1377-1380.
14. Michieletti P, Wanless IR, Katz A, Scheuer PJ, Yeaman SJ, Bassendine MF, Palmer JM, et al. Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis. Gut 1994;35:260-265.
15. Goodman Z, McNally PR, Davis DR, Ishak KO. Autoimmune cholangitis: a variant of primary biliary cirrhosis. Dig Dis Sci 1995;40:1232-1242.
16. Poupon RE, Poupon R, Balkau B, group U-PS. Ursodiol for the long-term treatment of primary biliary cirrhosis. N Engl J Med 1994;330:1342-1347.
17. Mitchison HC, Bassendine ME, Malcolm AF, Watson AJ, Record CO, James OFW. A pilot, double-blind, controlled 1-year trial of prednisolone treatment in primary biliary cirrhosis: hepatic improvement but greater bone loss. HEPATOLOGY 1989;10:420-429.
18. Duclos-Vallee JC, Hadengue A, Ganne-Carrie N, Ganne-Carrie N, Robin E, Degott C, Erlinger S. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome. Dig Dis Sci 1995;40:1069-1073.
19. Perrillo RP, Mason AL, Jacob S, Gerber MA. Hepatitis and cholestasis in a middle-aged woman. HEPATOLOGY 1996;24:730-734.
20. Ben-Ari Z, Dhillon AP, Sherlock S. Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis. HEPATOLOGY 1993;18:10-15.
21. Klöppel G, Seifert G, Lindner H, Dammermann R, Sack HJ, Berg PA. Histopathological features in mixed types of chronic aggressive hepatitis and primary biliary cirrhosis. Virchows Arch Pathol Anal Histol 1977;373:143-160.
22. Czaja AJ. Frequency and nature of the variant syndromes of autoimmune liver disease. HEPATOLOGY 1998;28:360-365.
23. Chazouilleres O, Wendum D, Serfaty L, Montembault S, Rosmorduc O, Poupon R. Primary biliary cirrhosis - autoimmune hepatitis overlap syndrome: clinical features and response to therapy. HEPATOLOGY 1998;28:296-301.
24. Manns M, Meyer zum Büschenfelde KH, Slusarczyk J, Dienes HP. Detection of liver-kidney microsomal autoantibodies by radioimmunoassay and their relation to antimitochondrial antibodies in inflammatory liver diseases. Clin Exp Immunol 1984;57:600-608.
25. Manns M, Gerken G, Kyriatsoulis A, Staritz M, Meyer zum Büschenfelde KH. Characterization of a new subgroup of autoimmune chronic active hepatitis by autoantibodies against a soluble liver antigen. Lancet 1987;i:292-294.
26. Manns M, Gerken G, Kyriatsoulis A, Trautwein C, Reske K, Meyer zum Büschenfelde KH. Two different subtypes of anti-mitochondrial antibodies are associated with primary biliary cirrhosis: identification and characterization by radioimmunoassay. HEPATOLOGY 1987;7:893-899.
27. Kyriatsoulis A, Manns M, Gerken G, Lohse AW, Ballhausen W, Reske K, Meyer zum Büschenfelde KH. Distinction between natural and pathological autoantibodies by immunoblotting and densitometric subtraction: liver-kidney-microsomal antibody (LKM) positive sera identify multiple antigens in human liver tissue. Clin Exp Immunol 1987;70:53-60.
28. Orth T, Gerken G, Meyer zum Büschenfelde KH, Mayet WJ. Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity. Z Gastroenterol 1997;35:113-122.
29. Bianchi L, Gudat E Chronic hepatitis. In: MacSween RNM, Anthony PP, Scheuer PJ, Burt AD, Portmann BC, eds. Pathology of the Liver. London: Churchill Livingstone, 1994:349-396.
30. Meyer zum Büschenfelde KH, Lohse AW. Autoimmune Hepatitis. N Engl J Med 1995;333:1004-1005.
31. Kanzler S, Gerken G, Dienes HP, Meyer zum Büschenfelde KH, Lohse AW. Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis-report of three cases. Z Gastroenterol 1997;35:571-578.
32. Farid NR. The Immunogenetics of Autoimmune Diseases. Boca Raton: CRC Press, 1991.
33. Wolfhagen FHJ, Hoogstraten HJF, van Buuren HR, van Berge-Hengouwen GP, ten Kate FJW, Hop WCJ, van der Hoek EW, et al. Triple therapy with ursodeoxycholic acid, prednisone and azathioprine in primary biliary cirrhosis: a 1-year randomized, placebo-controlled study. J Hepatol 1998;29:736-742.